Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open Label Randomised Controlled Clinical Trial of Different Dosing Regimens of Fludrocortisone in Septic Shock With Assessment of Temporal Changes in Hormonal, Inflammatory, and Genetic Markers of Vascular Responsiveness

NCT04494789 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT04494789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04494789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open Label Randomised Controlled Clinical Trial of Different Dosing Regimens of Fludrocortisone in Septic Shock With Assessment of Temporal Changes in Hormonal, Inflammatory, and Genetic Markers of Vascular Responsiveness
Lead sponsor
The George Institute
Phase
Phase 2
Overall status
Completed
Start date
February 11, 2021
Completion date
June 30, 2023
Enrollment
155 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, septic shock